BioPlus News Room

Featured News

Getting the Gold!
BioPlus Specialty Pharmacy Ensures Continuity of Care Ahead of Dorian
BioPlus Specialty Pharmacy in Semi-Exclusive Relationship to Dispense Vyleesi™ (Bremelanotide Injection)

Press Releases

RSS BioPlus Specialty Pharmacy – PRWeb Press Release Group

  • BioPlus Specialty Pharmacy Hires Brian Cherico as Chief Compliance and Privacy Officer December 3, 2019
    On the heels of new, comprehensive pharmacy accreditation and regulatory compliance standards introduced in late 2019, the Company reinforces its commitment to quality and compliance.(PRWeb December 03, 2019)Read the full story at https://www.prweb.com/releases/bioplus_specialty_pharmacy_hires_brian_cherico_as_chief_compliance_and_privacy_officer/prweb16752270.htm
  • BioPlus Specialty Pharmacy Announces Key Executives in Pharma and Payer Relations November 7, 2019
    New hires highlight continued growth for the independent specialty pharmacy that boasts #1 ranking by prescribers and patients.(PRWeb November 07, 2019)Read the full story at https://www.prweb.com/releases/bioplus_specialty_pharmacy_announces_key_executives_in_pharma_and_payer_relations/prweb16699116.htm
  • Patients Rank BioPlus #1 Among Independent Specialty Pharmacies October 31, 2019
    The top mark in patient satisfaction among independent specialty pharmacies in the most recent Zitter Health Insights’ Patient Satisfaction Survey goes to BioPlus Specialty Pharmacy.(PRWeb October 31, 2019)Read the full story at https://www.prweb.com/releases/patients_rank_bioplus_1_among_independent_specialty_pharmacies/prweb16682618.htm
  • BioPlus Specialty Pharmacy in Semi-Exclusive Relationship to Dispense Vyleesi™ (Bremelanotide Injection) August 29, 2019
    BioPlus Specialty Pharmacy, a leading innovative specialty pharmacy, will be one of only two specialty pharmacies filling prescriptions of the newly approved medication Vyleesi.(PRWeb August 29, 2019)Read the full story at https://www.prweb.com/releases/bioplus_specialty_pharmacy_in_semi_exclusive_relationship_to_dispense_vyleesi_bremelanotide_injection/prweb16529004.htm
  • BioPlus Specialty Pharmacy Dispensing Non-opioid Pain Medication Qutenza® (Capsaicin) 8% Patch in Exclusive Relationship June 6, 2019
    BioPlus Specialty Pharmacy, one of the nation’s leading innovative specialty pharmacies, announces an exclusive partnership to dispense Qutenza for post-shingles pain.(PRWeb June 06, 2019)Read the full story at https://www.prweb.com/releases/bioplus_specialty_pharmacy_dispensing_non_opioid_pain_medication_qutenza_capsaicin_8_patch_in_exclusive_relationship/prweb16360840.htm

Media Contact

Kelly Horner
BioPlus Specialty Pharmacy
+1 407-830-8820 Ext: 2945

BioPlus... Where Healing Begins in 2 Hours!

top100_2016_color
urac_accreditation
ACHC Accredited Oncology Logo
nasp